Combination Anti-HIV Antibody Infusions Suppress Virus for Sustained Period

NIAID scientists and their collaborators found that individuals with HIV who began taking antiretroviral therapy (ART) in the early stages of infection achieved a lengthy period of HIV suppression without ART after receiving multiple infusions of two broadly neutralizing anti-HIV antibodies (bNAbs), according to a small study published in the journal Nature. Although larger studies are needed, the findings suggest that combination bNAb therapy might offer a future alternative to daily ART for people living with HIV. Read more here. Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).                             This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107